A detailed history of Iconiq Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Iconiq Capital, LLC holds 6,362 shares of NVO stock, worth $555,847. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,362
Previous 1,601 297.38%
Holding current value
$555,847
Previous $228,000 232.02%
% of portfolio
0.02%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $566,892 - $692,344
4,761 Added 297.38%
6,362 $757,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $196,458 - $235,202
1,601 New
1,601 $228,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Iconiq Capital, LLC Portfolio

Follow Iconiq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iconiq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iconiq Capital, LLC with notifications on news.